Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-17 Sale |
2022-05-19 07:31 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
130,000 | $8.2159 | $1,068,067 | 1,387 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
33,579 | $7.4517 | $250,219 | 357,036 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 07:47 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
7,590 | $8.1422 | $61,799 | 108,875 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-10 4:09 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
6,116 | $9.0602 | $55,412 | 102,905 (Direct) |
View |
| 2021-08-10 Sale |
2021-08-12 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
50,860 | $9.9493 | $506,021 | 41,412 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 07:45 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
19,066 | $10.22 | $194,830 | 92,272 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
9,515 | $10.57 | $100,536 | 206,322 (Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
50,000 | $10.82 | $540,890 | 64,064 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
10,912 | $10.83 | $118,186 | 179,112 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-17 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
2,098 | $11.12 | $23,336 | 103,294 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
29,496 | $12.69 | $374,437 | 154,042 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-04 Exercise |
2022-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
94,157 | $0 | 357,036 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
140,750 | $0 | 357,036 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:47 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
21,682 | $0 | 108,875 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
16,121 | $0 | 102,905 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
51,488 | $0 | 102,905 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 07:45 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
37,884 | $0 | 92,272 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
18,905 | $0 | 206,322 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
95,057 | $0 | 206,322 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
21,682 | $0 | 179,112 (Direct) |
View |
| 2021-02-14 Exercise |
2021-02-17 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
5,355 | $0 | 103,294 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-11 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
16,120 | $0 | 154,042 (Direct) |
View |
| 2021-02-09 Option Award |
2021-02-11 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
105,736 | $0 | 154,042 (Direct) |
View |